Dynamin-Related Protein Drp1 Regulates Cardiac Excitation-Contraction-Bioenergetics Coupling

动力相关蛋白 Drp1 调节心脏兴奋-收缩-生物能耦合

基本信息

  • 批准号:
    10063889
  • 负责人:
  • 金额:
    $ 62.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-01-01 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Mitochondrial dynamics, including fission, fusion, and movement, is a fundamental mechanism in regulating mitochondrial function. Dynamin-related protein 1 (Drp1) is the major GTP hydrolyzing protein that is responsible for fission. Studies have shown that Drp1 is abundantly expressed in adult cardiac myocytes. Paradoxically, compared to numerous cell types, adult cardiac myocytes exhibit very low frequency in mitochondrial fission. This dichotomy between the abundance of Drp1 and scarcity of mitochondrial fission has prompted us to investigate the non-canonical roles of Drp1 in cardiac muscle cells. We hypothesize that Drp1 is strategically accumulated in the mitochondria associated sarcoplasmic reticulum (SR) membrane (MAM). During excitation- contraction coupling, the localized high Ca2+ in the SR-mitochondria junctions further increases the translocation of nearby cytosolic Drp1 to mitochondria. Then, Drp1 is anchored firmly in the MAM by actin. The activation of Drp1 leads to enhanced mitochondrial respiration for ATP generation as such the heart can work most effectively and sustainably. However, excessive Drp1 activation leads to persistent mitochondrial transition pore opening and excessive reactive oxygen species (ROS) generation that causes cell injury and death. The following three specific aims are proposed to test this hypothesis. Aim 1: To determine whether and how Drp1 is preferentially localized in the SR-mitochondria junctions. Aim 2: To determine the molecular mechanisms by which Drp1 regulates excitation-contraction-bioenergetics coupling. Aim 3: To determine how chronic over activation of Drp1 leads to dysfunction in the stressed heart. We will employ multiple techniques, including biochemistry (from in vitro to in situ assays), molecular biology (gene knock in or knock out, overexpression, RNA interference), cell biology (confocal, fluorescence resonance energy transfer, super-resolution microscopy, electron microscopy), cardiac physiology (echocardiogram, NMR spectroscopy), and isoproterenol infusion mouse model of cardiac hypertrophy and failure, to obtain experimental results that will lead to mechanistic insights. Successful completion of the proposed aims will allow us to introduce a new paradigm that describes the regulation of excitation-contraction-bioenergetics-ROS nexus by Drp1 through localized Ca2+ activation and actin anchoring. This fundamental signaling mechanism will describe not only how a healthy heart can perform perpetually in face of enormous workload but also why the over activation of this unique process can lead to heart failure. Finally, this new knowledge will provide new insights in developing and discovering therapeutic agents targeting Drp1-mediated signaling pathways for treating heart failure.
项目摘要/摘要 线粒体动力学,包括分裂、融合和运动,是 调节线粒体功能。动力蛋白相关蛋白1(Drp1)是GTP的主要水解物 负责裂变的蛋白质。研究表明,Drp1在 成年心肌细胞。矛盾的是,与众多细胞类型相比,成人心肌细胞 线粒体分裂的频率很低。在丰富的自然资源和自然资源之间 Drp1和线粒体分裂的稀缺性促使我们研究非典范作用。 DRP1在心肌细胞中的表达。我们假设Drp1在战略上积累在 线粒体相关肌浆网(SR)膜(MAM)。在激励过程中- 收缩偶联,肌浆网线粒体连接局部高钙进一步增加 邻近胞质的Drp1向线粒体的移位。然后,Drp1被牢固地锚定在 肌动蛋白的作用。DRp1的激活导致线粒体对ATP的呼吸增强 这样一代人的心才能最有效和可持续地工作。然而,过度 Drp1激活导致线粒体持续过渡孔洞开放和过度反应 氧物种(ROS)的产生,导致细胞损伤和死亡。下面是三个具体的 为了检验这一假说,我们提出了目标。目标1:确定Drp1是否以及如何 优先定位于SR-线粒体连接处。目的2:确定分子 DRp1调节兴奋-收缩-生物能耦合的机制。目标3:实现 确定长期过度激活的Drp1是如何导致应激心脏功能障碍的。我们会 使用多种技术,包括生物化学(从体外到原位分析)、分子 生物学(基因敲入或敲除、过表达、RNA干扰)、细胞生物学(共聚焦、 荧光共振能量转移,超分辨显微镜,电子显微镜), 心脏生理学(超声心动图、核磁共振波谱)和异丙肾上腺素注射小鼠 心肌肥厚和衰竭的模型,获得的实验结果将导致 机械的洞察力。成功完成拟议的目标将使我们能够推出一个新的 描述兴奋-收缩-生物能量学-ROS联系调节的范式 Drp1通过局部的钙激活和肌动蛋白锚定。这一基本信号 机制不仅描述了健康的心脏如何在面对 巨大的工作量,但也是为什么这一独特过程的过度激活会导致心脏 失败了。最后,这一新知识将为开发和发现 靶向Drp1介导的信号通路的治疗药物用于治疗心力衰竭。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊。
Unsolved mysteries and controversies of mitochondria in the heart- A Virtual Special Issue in JMCC: Part III.
心脏线粒体的未解之谜和争议 - JMCC 虚拟特刊:第三部分。
Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling.
  • DOI:
    10.1161/circulationaha.121.055841
  • 发表时间:
    2022-04-05
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Wang P;Xu S;Xu J;Xin Y;Lu Y;Zhang H;Zhou B;Xu H;Sheu SS;Tian R;Wang W
  • 通讯作者:
    Wang W
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC: Part II.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊:第二部分。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shey-Shing Sheu其他文献

Shey-Shing Sheu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shey-Shing Sheu', 18)}}的其他基金

Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure
心脏肥大和心力衰竭发病机制中 1 型和 2 型 Ryanodine 受体之间的串扰 Ca2 信号传导
  • 批准号:
    10660636
  • 财政年份:
    2023
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8011076
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8267661
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
  • 批准号:
    8311703
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8431698
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
  • 批准号:
    8198299
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    10521270
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    10064104
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    9887277
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8761519
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 62.87万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了